Wenhao Liao
Overview
Explore the profile of Wenhao Liao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
124
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liao W, Wang J, Li Y
J Pharm Anal
. 2025 Feb;
15(2):101075.
PMID: 39957902
Gastric carcinoma (GC) is a malignancy with multifactorial involvement, multicellular regulation, and multistage evolution. The classic Correa's cascade of intestinal GC specifies a trilogy of malignant transformation of the gastric...
2.
Zhao M, He Q, Shu X, Xu R, Zhang Z, Mou Y, et al.
Phytomedicine
. 2025 Feb;
138:156439.
PMID: 39892308
Background: Metabolic-associated fatty liver disease (MAFLD) is the leading chronic liver disease globally, impacting a large segment of the population. The Zhuyu Pill (ZYP), a traditional Chinese remedy, has been...
3.
Li Y, Zhou J, Zhang T, Li X, Wu C, Zhao Z, et al.
Sci Rep
. 2025 Jan;
15(1):2028.
PMID: 39815001
Acute kidney injury (AKI) has become a disease of global concern due to its high morbidity and mortality. This has highlighted the need for renoprotective agents. Astragaloside IV (AS-IV) is...
4.
Wang Z, Liu J, Mou Y, Li Y, Liao W, Yao M, et al.
Mol Med
. 2024 Dec;
30(1):245.
PMID: 39701924
Background: NLRP3 inflammasome immoderate activation results in the occurrence of various inflammatory diseases, but the clinic medications targeting NLRP3 inflammasome are still not available currently. The strategy of drug repurposing...
5.
Xin W, Zhou J, Peng Y, Gong S, Liao W, Wang Y, et al.
Adv Sci (Weinh)
. 2024 Dec;
12(6):e2412233.
PMID: 39680752
Acute kidney injury (AKI) is a prevalent clinical syndrome with high morbidity and mortality. Accumulating studies suggest mitochondrial dysfunction as the typical characteristics and key process of AKI, but the...
6.
Liao W, Li Y, Liu J, Mou Y, Zhao M, Liu J, et al.
Cell Commun Signal
. 2024 Jun;
22(1):315.
PMID: 38849890
Background: Aberrant inflammatory responses drive the initiation and progression of various diseases, and hyperactivation of NLRP3 inflammasome is a key pathogenetic mechanism. Pharmacological inhibitors of NLRP3 represent a potential therapy...
7.
Wang Z, Liu J, Mou Y, Liao W, Li Y, Liu J, et al.
Front Pharmacol
. 2024 May;
15:1296075.
PMID: 38708084
The metabolic disease hyperuricemia (HUA) is caused by presence of excessive serum uric acid (UA), which leads to an increased risk of chronic kidney disease and gout. As a widely...
8.
Glycyrrhizin and the Related Preparations: An Inspiring Resource for the Treatment of Liver Diseases
Mou Y, Liao W, Li Y, Wan L, Liu J, Luo X, et al.
Am J Chin Med
. 2024 Mar;
52(2):315-354.
PMID: 38553799
Liver diseases and their related complications endanger the health of millions of people worldwide. The prevention and treatment of liver diseases are still serious challenges both in China and globally....
9.
Wan L, Li Y, Liao W, Lei L, Zhao M, Zeng J, et al.
Sci Rep
. 2024 Feb;
14(1):4287.
PMID: 38383655
The SARS-CoV-2 virus, belonging to the Coronavirus genus, which poses a threat to human health worldwide. Current therapies focus on inhibiting viral replication or using anti-inflammatory/immunomodulatory compounds to enhance host...
10.
Zhao M, Wen Y, Yang Y, Pan H, Xie S, Shen C, et al.
Phytomedicine
. 2024 Feb;
126:155348.
PMID: 38335913
Background: (-)-Asarinin (Asarinin) is the primary component in the extract of the herb Asarum sieboldii Miq. It possesses various functions, including pain relief, anti-viral and anti-tuberculous bacilli effects, and inhibition...